跳至主要内容
临床试验/NL-OMON29180
NL-OMON29180尚未招募不适用

Evaluating the implementation of the 'Respiratory Adherence Care Enhancer' (RACE) instrument with complex multidimensional interventions to improve self-management, reach treatment goals and disease stability in asthma and Chronic Obstructive Pulmonary Disease (COPD) patients using inhaled maintenance therapy: an exploratory randomized controlled trial.

This study is supported by AstraZeneca and the Royal Dutch Pharmacists Association (KNMP) with an unconditional research grant.0 个研究点目标入组 400 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
400

研究概览

简要总结

The data obtained in this trial will be disclosed as an international publication.

研究设计

研究类型
Interventional

入排标准

入选标准

  • = 18 years of age
  • - Being treated for asthma with ICS maintenance therapy or
  • - Being treated for COPD with LAMA or LABA
  • according to dispensing data for these conditions present in the pharmacy information systems.
  • - Able to answer to online questionnaires

排除标准

  • - Concomitant asthma and COPD, suspicions hereof or diagnosed with other significant lung
  • diseases from information present in the pharmacy
  • - Incapability to speak, write and comprehend the Dutch language
  • - Presence of any cognitive impairments

研究者

发起方
This study is supported by AstraZeneca and the Royal Dutch Pharmacists Association (KNMP) with an unconditional research grant.

相似试验